Anuh Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE489G01022
  • NSEID: ANUHPHR
  • BSEID: 506260
INR
78.96
-0.61 (-0.77%)
BSENSE

Jun 18

BSE+NSE Vol: 37.66 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Kopran
Wanbury
Anlon Healthcare
Shree Ganesh Rem
Kilitch Drugs
Amanta Healthcar
Zim Laboratories
Anuh Pharma
Sigachi Indust.
Bharat Parenter.
Remus Pharma.
Why is Anuh Pharma Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 13.69% and Operating profit at 7.18% over the last 5 years
2
Negative results in Sep 25
  • PBT LESS OI(Q) At Rs 8.94 cr has Fallen at -29.3% (vs previous 4Q average)
  • PAT(Latest six months) At Rs 15.91 cr has Grown at -35.19%
  • ROCE(HY) Lowest at 15.90%
3
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 2.23% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -26.64% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Anuh Pharma for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Anuh Pharma
-24.3%
-0.68
39.21%
Sensex
-5.16%
0.43
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
12.30%
EBIT Growth (5y)
11.02%
EBIT to Interest (avg)
49.00
Debt to EBITDA (avg)
0.24
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
2.12
Tax Ratio
24.31%
Dividend Payout Ratio
15.87%
Pledged Shares
0
Institutional Holding
0.05%
ROCE (avg)
19.55%
ROE (avg)
15.22%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
20
Industry P/E
34
Price to Book Value
2.29
EV to EBIT
15.15
EV to EBITDA
12.33
EV to Capital Employed
2.52
EV to Sales
0.98
PEG Ratio
NA
Dividend Yield
1.86%
ROCE (Latest)
16.65%
ROE (Latest)
11.65%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
NET SALES(Q)

Highest at Rs 202.12 cr

PBDIT(Q)

Highest at Rs 19.88 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 9.84%

PBT LESS OI(Q)

Highest at Rs 16.77 cr.

-3What is not working for the Company
ROCE(HY)

Lowest at 15.53%

Loading Valuation Snapshot...
Here's what is working for Anuh Pharma
Net Sales - Quarterly
Highest at Rs 202.12 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 19.88 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 9.84%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 16.77 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)